These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 9229364)

  • 1. CD69 to CD3 ratio of peripheral blood mononuclear cells as a marker to monitor systemic lupus erythematosus disease activity.
    Su CC; Shau WY; Wang CR; Chuang CY; Chen CY
    Lupus; 1997; 6(5):449-54. PubMed ID: 9229364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonrenal and renal activity of systemic lupus erythematosus: a comparison of two anti-C1q and five anti-dsDNA assays and complement C3 and C4.
    Julkunen H; Ekblom-Kullberg S; Miettinen A
    Rheumatol Int; 2012 Aug; 32(8):2445-51. PubMed ID: 21706294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased Tim-3 expression on peripheral T lymphocyte subsets and association with higher disease activity in systemic lupus erythematosus.
    Song LJ; Wang X; Wang XP; Li D; Ding F; Liu HX; Yu X; Li XF; Shu Q
    Diagn Pathol; 2015 Jun; 10():71. PubMed ID: 26076826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of CD3+ CD4- CD8- (double negative) T cells in patients with systemic lupus erythematosus: activation markers.
    Anand A; Dean GS; Quereshi K; Isenberg DA; Lydyard PM
    Lupus; 2002; 11(8):493-500. PubMed ID: 12220103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasculitis in systemic lupus erythematosus (SLE)--assessment of peripheral blood mononuclear cell activation and the degree of endothelial dysfunction: initial report.
    Kluz J; Kopeć W; Jakobsche U; Prajs I; Adamiec R
    Postepy Hig Med Dosw (Online); 2007 Dec; 61():725-35. PubMed ID: 18063917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlations between antinucleosome antibodies and anti-double-stranded DNA antibodies, C3, C4, and clinical activity in lupus patients.
    Saisoong S; Eiam-Ong S; Hanvivatvong O
    Clin Exp Rheumatol; 2006; 24(1):51-8. PubMed ID: 16539819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
    Oelzner P; Deliyska B; Fünfstück R; Hein G; Herrmann D; Stein G
    Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and function of inducible costimulator on peripheral blood T cells in patients with systemic lupus erythematosus.
    Yang JH; Zhang J; Cai Q; Zhao DB; Wang J; Guo PE; Liu L; Han XH; Shen Q
    Rheumatology (Oxford); 2005 Oct; 44(10):1245-54. PubMed ID: 15987711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
    Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K
    Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum ferritin level correlates with SLEDAI scores and renal involvement in SLE.
    Tripathy R; Panda AK; Das BK
    Lupus; 2015 Jan; 24(1):82-9. PubMed ID: 25253568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-CII antibody as a novel indicator to assess disease activity in systemic lupus erythematosus.
    He C; Mao T; Feng Y; Song T; Qin C; Yan R; Feng P
    Lupus; 2015 Nov; 24(13):1370-6. PubMed ID: 26048288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urine neopterin as a parameter of disease activity in patients with systemic lupus erythematosus: comparisons with serum sIL-2R and antibodies to dsDNA, erythrocyte sedimentation rate, and plasma C3, C4, and C3 degradation products.
    Lim KL; Jones AC; Brown NS; Powell RJ
    Ann Rheum Dis; 1993 Jun; 52(6):429-35. PubMed ID: 8323394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The contribution of resting heart rate and routine blood tests to the clinical assessment of disease activity in systemic lupus erythematosus.
    Guzmán J; Cardiel MH; Arce-Salinas A; Alarcón-Segovia D
    J Rheumatol; 1994 Oct; 21(10):1845-8. PubMed ID: 7837148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of methotrexate on improving serological abnormalities of patients with systemic lupus erythematosus.
    Miyawaki S; Nishiyama S; Aita T; Yoshinaga Y
    Mod Rheumatol; 2013 Jul; 23(4):659-66. PubMed ID: 23011357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Serum free light chains for monitoring systemic lupus erythematosus activity].
    Żychowska I; Suszek D; Dryglewska M; Nurzyńska D; Donica H; Majdan M
    Wiad Lek; 2018; 71(1 pt 1):21-31. PubMed ID: 29558348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitivity and specificity of plasma and urine complement split products as indicators of lupus disease activity.
    Manzi S; Rairie JE; Carpenter AB; Kelly RH; Jagarlapudi SP; Sereika SM; Medsger TA; Ramsey-Goldman R
    Arthritis Rheum; 1996 Jul; 39(7):1178-88. PubMed ID: 8670328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The model of circulating immune complexes and interleukin-6 improves the prediction of disease activity in systemic lupus erythematosus.
    Thanadetsuntorn C; Ngamjanyaporn P; Setthaudom C; Hodge K; Saengpiya N; Pisitkun P
    Sci Rep; 2018 Feb; 8(1):2620. PubMed ID: 29422675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progressive reduction of serum complement levels: a risk factor for relapse in patients with hypocomplementemia in systemic lupus erythematosus.
    Miyawaki Y; Sada K; Asano Y; Hayashi K; Yamamura Y; Hiramatsu S; Ohashi K; Morishita M; Watanabe H; Matsumoto Y; Kawabata T; Wada J
    Lupus; 2018 Nov; 27(13):2093-2100. PubMed ID: 30309286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Role of circulating T follicular helper subsets and T follicular helper effector memory cells in systemic lupus erythematosus].
    Liang YC; Yao Y; Zhang RJ; Shao M; Sun XL; Shi GX; Gao C; Yu D; He J
    Zhonghua Yi Xue Za Zhi; 2019 Jan; 99(3):164-168. PubMed ID: 30669756
    [No Abstract]   [Full Text] [Related]  

  • 20. Associations of the Levels of C4d-bearing Reticulocytes and High-avidity Anti-dsDNA Antibodies with Disease Activity in Systemic Lupus Erythematosus.
    Mora C; Medina-Rosas J; Santos AM; Jaimes DA; Arbeláez AM; Romero C; Cortes A; Londono J
    J Rheumatol; 2016 Sep; 43(9):1657-64. PubMed ID: 27134246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.